Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. ATH
ATH logo

ATH Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--

Events Timeline

(ET)
2025-09-29
07:27:24
Athene Holding reveals reinsurance deal with Sony Life
select
2025-06-16 (ET)
2025-06-16
08:41:10
Athene Holding appoints Grant Kvalheim as CEO
select
2025-03-13 (ET)
2025-03-13
08:49:30
Apollo, Athene, Motive Ventures invest in ARS
select
2025-02-26 (ET)
2025-02-26
17:14:19
Athene Holding appoints Louis-Jacques Tanguy as CFO
select

News

Globenewswire
9.5
01-21Globenewswire
Alterity Therapeutics Completes Phase 2 Trials for ATH434, Targeting $2.4 Billion Market
  • Clinical Trial Success: In 2025, Alterity successfully completed Phase 2 trials for ATH434, demonstrating strong safety and efficacy signals, paving the way for a transition to Phase 3 trials, which is expected to unlock significant market opportunities.
  • Significant Market Potential: ATH434 targets Multiple System Atrophy (MSA), a condition currently lacking effective treatments, with a potential market size of $2.4 billion, and successful advancement will greatly enhance Alterity's competitive position in the biotech sector.
  • Regulatory Alignment Plans: Alterity plans to hold an End-of-Phase 2 meeting with the FDA in mid-2026 to finalize the design and key clinical endpoints for Phase 3 trials, ensuring compliance and effectiveness in clinical development.
  • Strengthened Leadership Team: In 2025, Alterity enhanced its governance structure by appointing Julian Babarczy as the new Chair of the Board, increasing the leadership team's expertise and market responsiveness, preparing for critical milestones in 2026.
NASDAQ.COM
8.0
01-13NASDAQ.COM
Apollo Global Management's ATH.PRE Shares Up 0.1% Amidst Common Shares Decline
  • Stock Performance: On Tuesday, Apollo Global Management's new shares ATH.PRE rose approximately 0.1%, while common shares APO fell about 1.4%, indicating the relative stability of preferred shares amidst market fluctuations.
  • Dividend History: The dividend history chart for ATH.PRE illustrates that its 7.750% rate reset non-cumulative feature provides investors with a stable income source, enhancing its attractiveness.
  • Market Reaction: Despite the poor performance of common shares APO, the slight increase in ATH.PRE suggests ongoing demand for preferred shares, potentially reflecting investor confidence in the company's financial health.
  • Investor Perspectives: The views and opinions expressed in the article do not necessarily reflect those of Nasdaq, highlighting the importance of diverse perspectives in market analysis.
Newsfilter
5.0
2025-07-30Newsfilter
Insurtech Leader Ethos Adds Industry Veteran William Wheeler to Board of Directors
  • Appointment of William J. Wheeler: Ethos, a life insurance technology company, has appointed William J. Wheeler to its Board of Directors, bringing over three decades of experience in the financial services industry, particularly in insurance and retirement services.

  • Ethos' Mission and Innovations: Ethos aims to democratize access to life insurance through a streamlined digital application process that eliminates traditional barriers, allowing families to obtain coverage quickly and easily without invasive medical exams.

Benzinga
4.0
2025-07-11Benzinga
Scotiabank Downgrades Athabasca Oil to Sector Perform, Announces C$6.5 Price Target
  • Real-time Intelligence: Benzinga Pro offers the fastest news alerts for traders, providing real-time intelligence to help them succeed in the stock market.

  • Community and Exclusivity: Joining Benzinga Pro connects users with over 10,000 serious traders and grants access to exclusive stories and insights from Benzinga reporters.

WSJ
8.5
2024-10-07WSJ
Chevron to Sell Oil Sands, Shale Assets for $6.5 Billion to Canadian Natural
  • Chevron's Divestment Strategy: Chevron plans to sell its stakes in oil sands and shale assets to Canadian Natural Resources for $6.5 billion as part of its goal to divest by 2028.

  • Details of the Sale: The sale includes Chevron Canada's 20% interest in the Athabasca Oil Sands Project and a 70% interest in the Duvernay shale, both located in Alberta.

Benzinga
4.0
2024-09-12Benzinga
RBC Capital Reiterates Sector Perform on Athabasca Oil, Maintains C$6 Price Target
  • Fastest News Alerts: Benzinga Pro offers real-time intelligence and news alerts to help traders stay informed and make winning trades in the stock market.

  • Exclusive Community: Joining Benzinga Pro connects users with over 10,000 serious traders and provides access to exclusive stories and insights from Benzinga reporters.

Wall Street analysts forecast ATH stock price to rise
0 Analyst Rating
Wall Street analysts forecast ATH stock price to rise
0 Buy
0 Hold
0 Sell
Current: 0.000
sliders
Low
Averages
High
Current: 0.000
sliders
Low
Averages
High
No data

No data

Valuation Metrics

The current forward P/E ratio for (ATH) is --, compared to its 5-year average forward P/E of --. For a more detailed relative valuation and DCF analysis to assess 's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PE
Current PE
NaN
Overvalued PE
Undervalued PE

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average EV/EBITDA
Current EV/EBITDA
NaN
Overvalued EV/EBITDA
Undervalued EV/EBITDA

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PS
Current PS
NaN
Overvalued PS
Undervalued PS

Financials

AI Analysis
Annual
Quarterly

Whales Holding ATH

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is (ATH) stock price today?

The current price of ATH is 0 USD — it has increased 0

What is (ATH)'s business?

What is the price predicton of ATH Stock?

Wall Street analysts forecast ATH stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for ATH is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is (ATH)'s revenue for the last quarter?

revenue for the last quarter amounts to NaN USD, decreased

What is (ATH)'s earnings per share (EPS) for the last quarter?

. EPS for the last quarter amounts to USD, decreased

How many employees does (ATH). have?

(ATH) has 0 emplpoyees as of April 04 2026.

What is (ATH) market cap?

Today ATH has the market capitalization of 0.00 USD.